Internal Medicine, Hematology & Oncology · La Jolla, CA
NPI
1760778526
Since 2011
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
3855 Health Sciences Dr # Mc0829, Moores Cancer Center Dept of Hematology/Oncology
La Jolla, CA, 92093
Phone (858) 822-6583
Groups this clinician bills Medicare through
Medicare paid, 2024
$40K
638 services
Medicare patients, 2024
116
Average age 71
Drug cost, 2024
$3.1M
642 prescriptions
Company payments, 2025
$19K
From 9 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Rebecca A Shatsky was code G2211 (visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's), 252 times for 80 patients. In total Rebecca A Shatsky billed 638 services in 14 codes, and Medicare paid $40K.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2017-07-28.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|---|---|---|---|---|
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Facility | 252 | 80 | $13.15 | $3,313 |
| 99215 Office E&M - Established | Facility | 204 | 50 | $112.18 | $23K |
| 99214 Office E&M - Established | Facility | 72 | 53 | $70.24 | $5,057 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 22 | 16 | $13.48 | $297 |
| 99215 Office E&M - Established | Office | 20 | 14 | $149.63 | $2,993 |
By year: 2022 $36K for 343 services; 2023 $46K for 482 services; 2024 $40K for 638 services.
Medicare prescription drug claims, 2024
In 2024, the drug Rebecca A Shatsky prescribed most often to Medicare patients was Ibrance (Palbociclib), with 35 prescriptions and refills. In total Rebecca A Shatsky wrote 642 Medicare prescriptions that cost $3.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Ibrance Palbociclib | 35 | 35 | Under 11 | $559K |
| Anastrozole Generic | 33 | 75 | Under 11 | $642 |
| Letrozole Generic | 31 | 59 | Under 11 | $342 |
| Orserdu Elacestrant Hcl | 31 | 31 | Under 11 | $697K |
| Everolimus Generic | 26 | 26 | Under 11 | $60K |
| Truqap Capivasertib | 21 | 21 | Under 11 | $475K |
| Zarxio Filgrastim-Sndz | 15 | 16 | Under 11 | $20K |
| Verzenio Abemaciclib | 14 | 14 | Under 11 | $200K |
| Ondansetron Odt Ondansetron | 13 | 13 | 11 | $135 |
| Pemazyre Pemigatinib | 13 | 13 | Under 11 | $229K |
| Ondansetron Hcl Generic | 13 | 13 | Under 11 | $42.59 |
| Trulicity Dulaglutide | 12 | 12 | Under 11 | $9,952 |
| Mekinist Trametinib Dimethyl Sulfoxide | 12 | 12 | Under 11 | $164K |
| Tukysa Tucatinib | 12 | 16 | Under 11 | $283K |
| Prednisone Generic | 12 | 12 | Under 11 | $79.63 |
Brand drugs: - claims; generic drugs: 388 claims; opioid claims: 13.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Rebecca A Shatsky $19K ($19K in general payments such as food, travel and fees) from 9 companies. The largest payer was AstraZeneca Pharmaceuticals LP with $5,036.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.